We are live on ! Find out more
PMSA

Patrick M. Sweeney & Associates Portfolio holdings

AUM $156M
1-Year Est. Return 19.16%
This Fund
S&P 500
This Quarter Est. Return
+0.83%
1 Year Est. Return
+19.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$133M
AUM Growth
-$2.6M
Cap. Flow
-$1.78M
Cap. Flow %
-1.34%
Top 10 Hldgs %
37.72%
Holding
154
New
3
Increased
69
Reduced
38
Closed
7

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$839K
2
NVO
Novo Nordisk
NVO
+$541K
3
FTNT icon
Fortinet
FTNT
+$222K
4
NFLX icon
Netflix
NFLX
+$208K
5
BXSL icon
Blackstone Secured Lending
BXSL
+$198K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.75M
2
BAC icon
Bank of America
BAC
+$506K
3
INTC icon
Intel
INTC
+$265K
4
HLN icon
Haleon
HLN
+$259K
5
ES icon
Eversource Energy
ES
+$216K

Sector Composition

Rank Sector Weight
1 Healthcare 23.65%
2 Financials 18.64%
3 Technology 15.64%
4 Industrials 14.36%
5 Consumer Staples 5.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXPI icon
151
NXP Semiconductors
NXPI
$65.4B
-864
Closed -$207K
O icon
152
Realty Income
O
$61.3B
-3,348
Closed -$212K
SO icon
153
Southern Company
SO
$109B
-2,293
Closed -$207K
STZ icon
154
Constellation Brands
STZ
$22.5B
-796
Closed -$205K

Similar funds

Patrick M. Sweeney & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Patrick M. Sweeney & Associates held 154 positions worth $133M, down 1.9% from $136M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Patrick M. Sweeney & Associates's Q4 2024 filing shows 3 new, 69 increased, 38 reduced and 7 closed positions. Its largest new stake was Fortinet: 2,500 shares worth $236K. The largest sale was CVS Health, an estimated $1.75M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Financials and Technology.

  • Patrick M. Sweeney & Associates's largest Q4 2024 buy was Fortinet: 2,500 shares worth $236K.
  • Patrick M. Sweeney & Associates added most to Pfizer in Q4 2024, an estimated $839K increase.
  • Patrick M. Sweeney & Associates's biggest Q4 2024 reduction was CVS Health, cutting an estimated $1.75M.
  • Patrick M. Sweeney & Associates fully exited Intel in Q4 2024, selling an estimated $265K.
  • Patrick M. Sweeney & Associates's ten largest holdings make up 38% of its $133M portfolio in Q4 2024.
  • Patrick M. Sweeney & Associates opened 3 new positions and closed 7 in Q4 2024.
  • Patrick M. Sweeney & Associates's portfolio value fell 1.9% quarter-over-quarter to $133M.

Based on Patrick M. Sweeney & Associates's 13F filing for Q4 2024, filed 22 Jan 2025.